Episode 20 is part two of our deeper understanding into NET research. Advancing NET research is the core of our mission at NETRF, and it’s a crucial need. This episode of NETWise will take a closer look at how scientists do the research that we hope will yield the next generation of effective treatments for NETs. This episode will also look specifically at the vital role NETRF plays in this process and how and why we choose the researchers we support.

After you’ve listened to the episode, test your NET Knowledge by taking the LACNETS quiz here. 

John Kanki, PhD
Director of Research
NETRF

Dawn Quelle, PhD 
Professor of Pharmacology and Neurology
Holden Comprehensive Cancer Center University of Iowa, College of Medicine
Co-Chair of NETRF Board of Scientific Advisors

Ramesh Shivdasani, MD, PhD 
Oncologist,
Dana-Farber Cancer Institute
Professor,
Harvard Medical School
NETRF Board of Scientific Advisors

Chrissie Thirlwell, MD, PhD
Mireille Gillings Professor of Cancer Genomics
University of Exeter 

Co-Chair of NETRF Board of Scientific Advisors

Request a Mailed Copy of our Neuroendocrine Cancer Guide

Information and Resources for the Newly Diagnosed

NETRF YouTube Channel

The post Episode 20: NET Research—Part Two appeared first on NETRF.